Newsroom
Welcome to Orion's newsroom where you can find the latest releases and articles.
Stock exchange releases
- 10/28/2025 Orion Group Interim Report January–September 2025
- 10/24/2025 49,164 Orion Corporation A shares converted into B shares
- 9/19/2025 80,802 Orion Corporation A shares converted into B shares
- 8/20/2025 337,000 Orion Corporation A shares converted into B shares
Press releases
- 11/14/2025 Orion receives award for international growth from the President of the Republic of Finland
- 10/23/2025 Orion and Abzena announce exclusive commercial license for Abzena’s antibody
- 10/14/2025 Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025
- 9/30/2025 Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal
Subscribe to releases
Subscribe Orion Corporation's stock exchange and press releases to your e-mail.
Subscribe
Orion Pharma content bank
You can find and download Orion Pharma brand assets in the content bank.
Sign in or registrate
Corporate Communications
-
Terhi Ormio
Vice President, Communications; primary media contact -
-
-
-